NYSE: WAT
Waters Corp Stock

$350.88+5.42 (+1.57%)
Updated May 8, 2025
WAT Price
$350.88
Fair Value Price
N/A
Market Cap
$20.88B
52 Week Low
$279.24
52 Week High
$423.56
P/E
31.73x
P/B
10.64x
P/S
7.22x
PEG
2.56x
Dividend Yield
N/A
Revenue
$2.98B
Earnings
$657.02M
Gross Margin
59.3%
Operating Margin
28.87%
Profit Margin
22%
Debt to Equity
1.34
Operating Cash Flow
$759M
Beta
0.94
Next Earnings
N/A
Ex-Dividend
N/A
Next Dividend
N/A

WAT Overview

Waters Corporation manufactures, sells, and services ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, and other consumable products. Its MS technology instruments are used in clinical trial drug testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Waters was founded in 1958 and is headquartered in Milford, MA.

Zen Rating

Our proven quant model uses 115 proprietary factors, including AI, to determine WAT's potential to beat the market

CHold
  • Stocks with a Zen Rating of Hold (C) had an average return of +7.53% per year. Learn More

Zen Rating Component Grades

B
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.

Industry: Diagnostic & Research

Industry Rating
C
WAT
Ranked
#8 of 43

Top Ranked Stocks in Industry

Name / TickerPriceZen Rating
$42.16A
$79.58B
$13.23B
View Top Diagnostic & Research Stocks

Be the first to know about important WAT news, forecast changes, insider trades & much more!

WAT News

Overview

Due Diligence Score

Industry Average (27)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how WAT scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

WAT ($350.88) is trading above its intrinsic value of $108.61, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
WAT is poor value based on its earnings relative to its share price (31.73x), compared to the US market average (24.22x)
P/E vs Market Valuation
WAT is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 30 more WAT due diligence checks available for Premium users.

Valuation

WAT price to earnings (PE)

For valuing profitable companies with steady earnings

Company
31.73x
Industry
30.87x
Market
24.22x
WAT is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
WAT is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

WAT price to book (PB)

For valuing companies that are loss-making or have lots of physical asset

Company
10.64x
Industry
3.39x
WAT is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

WAT price to earnings growth (PEG)

For valuing profitable companies with growth potential

WAT is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

WAT's financial health

Profit margin

Revenue
$661.7M
Net Income
$121.4M
Profit Margin
18.3%
WAT's Earnings (EBIT) of $861.33M... subscribe to Premium to read more.
Interest Coverage Financials
WAT's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$4.6B
Liabilities
$2.6B
Debt to equity
1.34
WAT's short-term assets ($1.74B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
WAT's short-term assets ($1.74B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
WAT's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
WAT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$259.6M
Investing
-$26.2M
Financing
-$173.2M
WAT's operating cash flow ($758.81M)... subscribe to Premium to read more.
Debt Coverage Financials

WAT vs Diagnostic & Research Stocks

TickerZen RatingMarket Cap1d %P/EP/B
WATC$20.88B+1.57%31.73x10.64x
LHC$20.82B+1.16%28.53x2.51x
NTRAB$21.98B+1.54%-106.25x18.38x
DGXC$19.64B-0.38%21.96x2.83x
MTDC$22.89B+1.58%27.38x-125.81x

Waters Stock FAQ

What is Waters's quote symbol?

(NYSE: WAT) Waters trades on the NYSE under the ticker symbol WAT. Waters stock quotes can also be displayed as NYSE: WAT.

If you're new to stock investing, here's how to buy Waters stock.

What is the 52 week high and low for Waters (NYSE: WAT)?

(NYSE: WAT) Waters's 52-week high was $423.56, and its 52-week low was $279.24. It is currently -17.16% from its 52-week high and 25.66% from its 52-week low.

How much is Waters stock worth today?

(NYSE: WAT) Waters currently has 59,509,089 outstanding shares. With Waters stock trading at $350.88 per share, the total value of Waters stock (market capitalization) is $20.88B.

Waters stock was originally listed at a price of $9.53 in Dec 31, 1997. If you had invested in Waters stock at $9.53, your return over the last 27 years would have been 3,580.69%, for an annualized return of 14.29% (not including any dividends or dividend reinvestments).

How much is Waters's stock price per share?

(NYSE: WAT) Waters stock price per share is $350.88 today (as of May 8, 2025).

What is Waters's Market Cap?

(NYSE: WAT) Waters's market cap is $20.88B, as of May 9, 2025.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Waters's market cap is calculated by multiplying WAT's current stock price of $350.88 by WAT's total outstanding shares of 59,509,089.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.